Publication entries for spray pattern
Alyssa Newcomb1, Dino J. Farina1, Ben Okorodudu1 1Proveris Scientific Corporation, 290 Donald Lynch Blvd, Suite 100, Marlborough, MA, U.S.A. Keywords Pressurized metered dose inhaler (“pMDI”), design of experiments (“DoE”), shaking duration, spray pattern, dose content uniformity (“DCU”), aerodynamic particle size distribution (“APSD”) Poster presentation at Inhalation Asia 2015. Contact Inhalation Asia for further information.
Pitluk Z, Pallas S, Graaf J, Farina D. Comparison of impaction and non-impaction methods for measuring spray patterns for MDIs. Drug Delivery to the Lung. 2013. Contact Drug Delivery to the Lung, sponsored by the Aerosol Group, for further information.
Coowanitwong I, De S. Spray pattern and plume geometry analysis of a nasal peptide formulation in an Aptar Unit Dose Powder (UDP) device. Respiratory Drug Delivery. 2012. Contact the Respiratory Drug Delivery for further information.
Wilcox D, Lacombe J, Brown J, Richardson M, Davies-Cutting C. Case study: does spray pattern testing provide a discriminating measure of Metered Dose Inhaler (MDI) product performance? Respiratory Drug Delivery. 2010. Contact the Respiratory Drug Delivery for further information.
Lacombe JP, Wilcox DM. Effect of force-displacement profile on the spray pattern of pressurized metered dose inhalers using SprayVIEW®. Respiratory Drug Delivery. 2010. Contact the Respiratory Drug Delivery for further information.
Journal of Pharmaceutical Sciences, 99(4):2114-2122 (April 2010). Guo C1, Doub WH, Kauffman JF. Corresponding author: email@example.com 1Division of Pharmaceutical Analysis, U.S. Food and Drug Administration, 1114 Market Street, Room 1002, St. Louis, Missouri 63101 Abstract Design of experiment (DOE) methodology can provide a complete evaluation of the influences of nasal spray activation and formulation properties on delivery performance […]
European Journal of Pharmaceutical Sciences, 35(5):418-426 (September 2008). Guo Ca, Stine KJb, Kauffman JFa, Doub WHa. Corresponding author: firstname.lastname@example.org aDivision of Pharmaceutical Analysis, U.S. Food and Drug Administration, 1114 Market Street, Room 1002, St. Louis, MO 63101, United States bDepartment of Chemistry and Biochemistry and Center for Nanoscience, University of Missouri at St. Louis, 315 Benton Hall, One University […]
Drug Development and Industrial Pharmacy, 34(9):923-929 (September 2008). Pennington J, Pandey P, Tat H, Willson J, Donovan B. Corresponding author: email@example.com Schering Plough Research Institute, Oral and Respiratory Product Development, Summit, NJ, USA. Abstract Aqueous suspension corticosteroid nasal sprays exhibit the rheological property of shear thinning, meaning they exhibit a decrease in viscosity upon application of shear. Most rheological methods […]
Drug Development and Industrial Pharmacy, 32:1033-1041 (2006). Smyth H1, Hickey AJ1, Brace G2, Barbour T3, Gallion J4, Grove J5. Corresponding author: firstname.lastname@example.org 1School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 2Straightforward Solutions, LLC, Raleigh, North Carolina 3Bespak Inc., Apex, North Carolina 4Polyzen, Inc. Apex, North Carolina 5AXON Corporation, Raleigh, North Carolina Abstract Factors that influence spray pattern measurements […]
Journal of Pharmaceutical Sciences, 95(9):2029-2040 (September 2006). Guo C, Doub WH. Corresponding author: email@example.com Division of Pharmaceutical Analysis, U. S. Food and Drug Administration, 1114 Market Street, Room 1002, St. Louis, Missouri 63101 Abstract Nasal spray drug products are normally characterized via measurement of shot weight, spray pattern, plume geometry, and droplet size distribution (DSD). In this […]